Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (221-230 of 441) with videos related to

Pageof 45
Sort By:
JCO Precision Oncology|July 12, 2023
Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of <i>FGFR2-KIAA1598</i> Gene FusionEleonora Nicolò, Laura Munoz-Arcos, Elena Vagia, et al.
Journal of the National Cancer Institute|September 17, 2020
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast CancerBen O'Leary, Rosalind J Cutts, Xin Huang, et al.
The Breast Journal|April 23, 2010
Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancerJames M Reuben, Bang-Ning Lee, Changping Li, et al.
Journal of Neuro-Oncology|March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanomaMorris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
Cancer Letters|July 18, 2016
GSK-3 inhibition overcomes chemoresistance in human breast cancerAndrey Ugolkov, Irina Gaisina, Jin-San Zhang, et al.
Oncotarget|December 29, 2016
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical applicationYoung Kwang Chae, Keerthi Ranganath, Peter S Hammerman, et al.
Cancer Treatment Reviews|January 21, 2017
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug developmentRicardo Costa, Ami N Shah, Cesar A Santa-Maria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch systemSabine Riethdorf, Herbert Fritsche, Volkmar Müller, et al.
Breast Cancer Research : BCR|December 3, 2020
Immune phenotype of patients with stage IV metastatic inflammatory breast cancerSandra V Fernandez, Alexander W MacFarlane, Mowafaq Jillab, et al.
Future Oncology (London, England)|March 9, 2023
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summaryHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Pageof 45

Showing results (221-230 of 441) with videos related to

Sort By:
Pageof 45
JCO Precision Oncology|July 12, 2023
Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of <i>FGFR2-KIAA1598</i> Gene FusionEleonora Nicolò, Laura Munoz-Arcos, Elena Vagia, et al.
Journal of the National Cancer Institute|September 17, 2020
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast CancerBen O'Leary, Rosalind J Cutts, Xin Huang, et al.
The Breast Journal|April 23, 2010
Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancerJames M Reuben, Bang-Ning Lee, Changping Li, et al.
Journal of Neuro-Oncology|March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanomaMorris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
Cancer Letters|July 18, 2016
GSK-3 inhibition overcomes chemoresistance in human breast cancerAndrey Ugolkov, Irina Gaisina, Jin-San Zhang, et al.
Oncotarget|December 29, 2016
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical applicationYoung Kwang Chae, Keerthi Ranganath, Peter S Hammerman, et al.
Cancer Treatment Reviews|January 21, 2017
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug developmentRicardo Costa, Ami N Shah, Cesar A Santa-Maria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch systemSabine Riethdorf, Herbert Fritsche, Volkmar Müller, et al.
Breast Cancer Research : BCR|December 3, 2020
Immune phenotype of patients with stage IV metastatic inflammatory breast cancerSandra V Fernandez, Alexander W MacFarlane, Mowafaq Jillab, et al.
Future Oncology (London, England)|March 9, 2023
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summaryHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Pageof 45